Bills Calling For Non-Pharma Alternatives To Opioids Clear US House
Executive Summary
Several bills that try to lift barriers to development and use of device alternatives for pain management in response to the opioid crisis were recently approved by the US House.
You may also be interested in...
Payment 'Sunshine' Requirements Would Expand For Industry Under Senate-Passed Opioid Bill
A provision to expand Sunshine Act industry reporting requirements for companies in the Senate-passed “Opioid Crisis Response Act” has caught criticism from the device sector, despite overall industry support for the legislation.
Bills Supporting Device Opioid Alternatives Advance In House
The House Energy and Commerce Committee approved four opioid crisis-related bills that call for US FDA meetings and consideration of streamlined pathways for medtech alternatives to opioids, and for a report and action by the US Medicare agency on overcoming payment challenges to device pain control products.
Advancing Bill Would Require Medicare Plans To Highlight Device Opioid Alternatives
The House Energy and Commerce Committee on May 9 approved, and sent to the full chamber, a bill requiring Medicare Part D drug plans to highlight information for prescribers on covered non-opioid pain devices and alternative medications.